The iQ Group Global

Antisoma Therapeutics, a medical technology company and member of The iQ Group Global, has received a worldwide license from the Wyss Institute for Biologically Inspired Engineering at Harvard University to commercialise the Institute's eRapid multiplexed biosensor technology. Antisoma will use the license to create a rapid point-of-care diagnostics test platform for COVID-19 and multiple other disease biomarkers.

The iQ Group Global secures worldwide license for Harvard University’s eRapid technology for at-home diagnostic testing  - The iQ Group Global Antisoma Therapeutics Pty Ltd., a medical technology company and member of The iQ Group Global, today announced it has received a worldwide license from Harvard’s Office of Technology Development to commercialise diagnostic technology developed at the Wyss Institute for Biologically Inspired Engin...

NEWS: OncoTEX Inc. appoints Chief Executive Officer, Dr Jonathan Arambula.

“This is a momentous and exciting next step for OncoTEX as we solidify our vision for the future and provide hope to countless patients across the globe living with incurable diseases,” Dr. Arambula said.

Read the full announcement here:

OncoTEX Inc. appoints Chief Executive Officer - OncoTEX Inc. OncoTEX Inc. (OncoTEX), a US oncology company and member of The iQ Group Global Ltd portfolio (NSX.IQG), is pleased to announce it has appointed Dr. Jonathan F. Arambula as Chief Executive Officer.

Engineers at MIT and Harvard University have designed a small tabletop device that can detect SARS-CoV-2 from a saliva sample in an hour. In a new study, they showed that the diagnostic is just as accurate as the PCR tests now used.

Read more here: https://www.sciencedaily.com/releases/2021/08/210806155901.htm

New device can diagnose COVID-19 from saliva samples: The tabletop diagnostic yields results in an hour and can be programmed to detect variants of the SARS-CoV-2 virus A new device can detect SARS-CoV-2 from saliva in about an hour. Researchers report that the diagnostic is just as accurate as PCR tests and can identify COVID-19 variants.

NEWS: GBS Inc. engages L.E.K. Consulting Hong Kong Pty Limited to identify potential sublicensees in China for its Saliva-Glucose diabetes test.

"China is a prominent and complex market, thus it’s essential we collaborate with the right partners early to maximize our product launch,” GBS Chief Executive Officer Harry Simeonidis said.

Read more here:

GBS Inc. Engages L.E.K. Consulting Hong Kong Pty Limited to Identify Potential Sublicensees in China for its Saliva-Glucose Diabetes Test - GBS Inc. New York, New York July 26, 2021 GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today [...]

NEWS: Australian Broadcasting Corporation (ABC) Radio interview by Fran Kelly with GBS Inc.’s Scientific Board Member, Professor Paul Dastoor, from the University of Newcastle. In the interview, Professor Dastoor discusses the mechanism behind the innovative technology:

“The glucose biosensor has the potential to help close to half a billion people around the world… we've been able to develop sensors that we can print using electronic inks that can detect glucose at concentrations that are a hundred times lower than the glucose is in your blood. And that's important because glucose is in your saliva.

What we're able to do is because these things are all based on carbon and biomolecules. Things like enzymes are also based on carbon, we've been able to stir them directly into the transistor ink and then use that right at the point where the transistor is most sensitive. And so, we embed, for example, in this case, an enzyme for glucose, right in the transistor structure. And that's how we get that amazing sensitivity.”

Professor Paul Dastoor Interview with ABC's Fran Kelly

This National Diabetes Week, we are unmasking the world’s largest epidemic, Diabetes, to raise awareness about the nature of the disease and the real impact diabetes-related stigmas have on all aspects of life for people living with this disease, including their mental health and wellbeing.

Read more: https://theiqgroupglobal.com/news/diabetes-the-worlds-largest-epidemic-unmasked/

Diabetes Australia